EUROPE BOTULINUM TOXIN MARKET 2021-2028

Lifesciences | Healthcare & Wellness

EUROPE BOTULINUM TOXIN MARKET 2021-2028

Market by Type, Application, End-user, and Country Outlook | Forecast 2021-2028

Request For Customization

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton’s research on Europe’s botulinum toxin market shows that it will progress with a CAGR of 5.58% in terms of revenue over the forecasting period from 2021 to 2028.


Report scope can be customized per your requirements. Request For Customization

The countries considered in the market in this region are:

•           The United Kingdom

•           Russia

•           France

•           Germany

•           Spain

•           Italy

•           Rest of Europe countries

The United Kingdom is known for aesthetic procedures, both invasive and non-invasive cosmetic treatments. The UK’s botulinum toxin market is witnessing rapid growth, thanks to factors like the increase in product approvals and the rise in acceptance of botulinum toxin by the population. 

An article published by the BAAPS Association in 2019 states that, the demand for non-surgical treatments in the country is on the rise. According to the association, non-invasive treatments for men gained popularity in 2018, fueled by the latest social trends to look tweaked rather than tucked. The decline in brow lift procedures among both women and men has underlined the value of botulinum toxin injections as an alternative. According to the ISAPS, there are more than 500 plastic surgeons in the United Kingdom at present, and this number is expected to rise in the future. All these factors are contributing to the botulinum toxin market’s growth in the country, in the coming years.

Germany is expected to observe strong growth in the number of botulinum toxin-based procedures performed, thanks to the rising public awareness, increase in the aging population, and the growing inclination toward youthful appearances. The ISAPS has stated that the number of cosmetic procedures performed in the country amount to nearly 4% of the total procedures performed globally. In addition, botulinum toxin injection was the most commonly performed non-surgical procedure in 2018, and this number is steadily growing. This has encouraged several companies, including the international players, to enter the market. All these factors are expected to positively influence the studied market growth in Germany in the forthcoming period.

Ipsen SA is a globally renowned biopharmaceutical company. It is engaged in the R&D, manufacture, and sale of pharmaceutical products across the world. The company operates in two primary segments, Consumer Healthcare and Specialty Care. Ipsen markets around 20 drugs. Established in 1929, the company is headquartered in Boulogne-Billancourt, France. It is a subsidiary of Mayroy SA.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. EUROPE BOTULINUM TOXIN MARKET – SUMMARY     

2. INDUSTRY OUTLOOK  

2.1. KEY INSIGHTS      

2.1.1. SURGE IN DISPOSABLE INCOME         

2.1.2. GROWING NUMBER OF MEN OPTING FOR COSMETIC TREATMENT   

2.1.3. DEVELOPMENT OF HEALTHCARE INFRASTRUCTURE    

2.2. IMPACT OF COVID-19 ON THE BOTULINUM TOXIN INDUSTRY

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1. THREAT OF NEW ENTRANTS    

2.3.2. THREAT OF SUBSTITUTE

2.3.3. BARGAINING POWER OF SUPPLIERS

2.3.4. BARGAINING POWER OF BUYERS      

2.3.5. THREAT OF COMPETITIVE RIVALRY  

2.4. MARKET ATTRACTIVENESS MATRIX

2.5. VENDOR SCORECARD 

2.6. KEY MARKET STRATEGIES     

2.6.1. NEW PRODUCT LAUNCHES      

2.7. MARKET DRIVERS         

2.7.1. INCREASING DEMAND FOR AESTHETIC PROCEDURES 

2.7.2. EXPANSION OF BOTULINUM TOXIN INTO THERAPEUTIC APPLICATIONS     

2.8. MARKET RESTRAINTS  

2.8.1. ADVERSE EFFECTS ASSOCIATED WITH BOTULINUM TOXIN     

2.8.2. LACK OF REIMBURSEMENT POLICIES SUPPORTING COSMETIC PROCEDURES   

2.8.3. LACK OF INTERCHANGEABILITY BETWEEN BOTULINUM TOXIN PRODUCTS

2.9. MARKET OPPORTUNITIES       

2.9.1. INCREASING AGING POPULATION      

2.9.2. RISE IN MEDICAL TOURISM       

3. EUROPE BOTULINUM TOXIN MARKET – BY TYPE         

3.1. TYPE A       

3.2. TYPE B       

4. EUROPE BOTULINUM TOXIN MARKET – BY APPLICATION     

4.1. COSMETIC APPLICATIONS      

4.1.1. GLABELLAR LINES

4.1.2. LATERAL CANTHAL LINES (CROW’S FEET)  

4.1.3. FOREHEAD LINES 

4.1.4. OTHER COSMETIC APPLICATIONS     

4.2. NON-COSMETIC APPLICATIONS        

4.2.1. DYSTONIA   

4.2.2. CHRONIC MIGRAINE        

4.2.3. OPHTHALMOLOGIC DISORDERS         

4.2.4. OTHER NON-COSMETIC APPLICATIONS       

5. EUROPE BOTULINUM TOXIN MARKET – BY END-USER          

5.1. HOSPITALS           

5.2. CLINICS AND OTHERS  

6. EUROPE BOTULINUM TOXIN MARKET – REGIONAL OUTLOOK                    

6.1. COUNTRY ANALYSIS    

6.1.1. UNITED KINGDOM 

6.1.2. GERMANY   

6.1.3. FRANCE       

6.1.4. SPAIN

6.1.5. ITALY 

6.1.6. RUSSIA         

6.1.7. REST OF EUROPE            

7. COMPETITIVE LANDSCAPE 

7.1. ABBVIE INC           

7.2. EVOLUS INC

7.3. GALDERMA PHARMA SA (ACQUIRED BY EQT)      

7.4. HUGEL INC

7.5. IPSEN PHARMA   

7.6. MERZ PHARMA   

7.7. MEDYTOX INC

7.8. REVANCE THERAPEUTICS INC

7.9. US WORLDMEDS LLC    

8. METHODOLOGY & SCOPE    

8.1. RESEARCH SCOPE & DELIVERABLES        

8.2. SOURCES OF DATA       

8.3. RESEARCH METHODOLOGY   

List of Tables

TABLE 1: EUROPE BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 2: MARKET ATTRACTIVENESS MATRIX

TABLE 3: VENDOR SCORECARD

TABLE 4: LIST OF NEW PRODUCT LAUNCHES

TABLE 5: EUROPE BOTULINUM TOXIN MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 6: EUROPE BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 7: EUROPE BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

TABLE 8: EUROPE BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

TABLE 9: EUROPE BOTULINUM TOXIN MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 10: EUROPE BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1: PORTER’S FIVE FORCES ANALYSIS

FIGURE 2: EUROPE BOTULINUM TOXIN MARKET, BY TYPE, 2020 & 2028 (IN %)

FIGURE 3: EUROPE BOTULINUM TOXIN MARKET, BY TYPE A, 2021-2028 (IN $ MILLION)

FIGURE 4: EUROPE BOTULINUM TOXIN MARKET, BY TYPE B, 2021-2028 (IN $ MILLION)

FIGURE 5: EUROPE BOTULINUM TOXIN MARKET, BY APPLICATION, 2020 & 2028 (IN %)

FIGURE 6: EUROPE BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 7: EUROPE BOTULINUM TOXIN MARKET, BY GLABELLAR LINES, 2021-2028 (IN $ MILLION)

FIGURE 8: EUROPE BOTULINUM TOXIN MARKET, BY LATERAL CANTHAL LINES (CROW’S FEET), 2021-2028 (IN $ MILLION)

FIGURE 9: EUROPE BOTULINUM TOXIN MARKET, BY FOREHEAD LINES, 2021-2028 (IN $ MILLION)

FIGURE 10: EUROPE BOTULINUM TOXIN MARKET, BY OTHER COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 11: EUROPE BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 12: EUROPE BOTULINUM TOXIN MARKET, BY DYSTONIA, 2021-2028 (IN $ MILLION)

FIGURE 13: EUROPE BOTULINUM TOXIN MARKET, BY CHRONIC MIGRAINE, 2021-2028 (IN $ MILLION)

FIGURE 14: EUROPE BOTULINUM TOXIN MARKET, BY OPHTHALMOLOGIC DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 15: EUROPE BOTULINUM TOXIN MARKET, BY OTHER NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 16: EUROPE BOTULINUM TOXIN MARKET, BY END-USER, 2020 & 2028 (IN %)

FIGURE 17: EUROPE BOTULINUM TOXIN MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)

FIGURE 18: EUROPE BOTULINUM TOXIN MARKET, BY CLINICS AND OTHERS, 2021-2028 (IN $ MILLION)

FIGURE 19: EUROPE BOTULINUM TOXIN MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 20: UNITED KINGDOM BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 21: GERMANY BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 22: FRANCE BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 23: SPAIN BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 24: ITALY BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 25: RUSSIA BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 26: REST OF EUROPE BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)


Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying